Increased EBITDA and positive cash flow
First quarter at a glance
Significant events during the quarter:
- Sales increased by 2% compared to the corresponding quarter in 2023 and the gross margin increased from 42% to 45%. Sequentially, revenue increased by 5% compared to the fourth quarter of 2023.
-
EBITDA increased to
SEK 2,212,000 , which is a sequential increase of 42% compared to the fourth quarter of 2023. - The cost saving program has run according to plan and has had full effect at the end of the quarter.
- Performance Masterbatch's sales decreased by 9% compared to the corresponding quarter in 2023, while Performance Chemical increased by 17%.
-
Researchers from the
Department of Applied Science and Technology at Politecnico diTorino, Italy have validatedNexam's additives for recycled polypropylene.
Financials during the first quarter 2024:
- Net sales during quarter amounted to
SEK 53,219,000 (52,234,000). - The gross margin amounted to 45% (42%) during the quarter.
-
The operating profit before depreciation (EBITDA) for the quarter was
SEK 2,212,000 (119,000). -
In comparison to the beginning of the year, cash and cash equivalents amounted to
SEK 9,909,000 (9,056,000). -
Cash flow from the operating activities during the quarter amounted to
SEK 3,622,000 (10,698,000). -
Earnings per share before and after dilution amounted to
SEK -0.02 (-0.04) for the quarter.
Lomma
The Board of Directors
These financial statements haven't been reviewed by the Company's auditor.
Presentation:
The presentation will be held in English via the following link: https://youtube.com/live/l8N_Sjra9nQ
Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.
For further information please contact:
Ronnie Törnqvist, VD, +46 (0)706-25 41 85, ronnie.tornqvist@nexamchemical.com
Certified Adviser:
This information is information that
About
https://news.cision.com/nexam-chemical/r/nexam-chemical-holding-ab--publ--interim-report-1-january---31-march-2024,c3963084
https://mb.cision.com/Main/6364/3963084/2738540.pdf
(c) 2024 Cision. All rights reserved., source